Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00026338 | Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer | ||
| NCT02537418 | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens | ||
| NCT00028015 | SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer | ||
| NCT04000776 | 3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer | ||
| NCT00225927 | Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers | ||
| NCT01881022 | An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer | ||
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | ||
| NCT00258375 | OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | ||
| NCT04093167 | Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer | ||
| NCT03914612 | Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer | ||
| NCT02511522 | Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases | ||
| NCT00083174 | Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer | ||
| NCT01089933 | Reducing Pain and Disability After Breast Cancer Surgery | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | ||
| NCT05116137 | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors | ||
| NCT03548636 | Project MOVE: Increasing Physical Activity Among Breast Cancer Survivors | ||
| NCT00930332 | Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain | ||
| NCT06880523 | STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma | ||
| NCT00075660 | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma | ||
| NCT00028743 | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT05863910 | Real World Evidence on the Use of Medical Cannabis in Pediatrics | ||
| NCT02637024 | Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation | ||
| NCT01656538 | A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer | ||
| NCT00079066 | Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer | ||
| NCT00956384 | One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure | ||
| NCT06776458 | Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer | ||
| NCT03847649 | A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies | ||
| NCT04224974 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | ||
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT06193369 | Digital Peer Navigation for Adolescents and Young Adults With Cancer | ||
| NCT02111239 | Preoperative Imaging in DIEP Flap Breast Reconstruction | ||
| NCT01948128 | Effects of Vitamin D in Patients With Breast Cancer | ||
| NCT00156039 | Randomized Trial of Follow-up Strategies in Breast Cancer | ||
| NCT00003892 | ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer | ||
| NCT03277898 | Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer | ||
| NCT00188708 | Effect of Casodex on Tumour Hypoxia - Prostate Cancer | ||
| NCT05515354 | Smoking Cessation and Menstrual Cycle Phase | ||
| NCT01627054 | A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia | ||
| NCT00522262 | Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial | ||
| NCT01000025 | PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer | ||
| NCT00993655 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | ||
| NCT00005970 | Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer | ||
| NCT05998642 | Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma | ||
| NCT05451004 | SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer | ||
| NCT00064116 | Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma | ||
| NCT00354302 | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial | ||
| NCT00275353 | Effectiveness of an Individualized Symptom Education Program (ISEP) | ||
| NCT00030875 | Bortezomib in Treating Patients With Mantle Cell Lymphoma | ||
| NCT03548077 | POWERPLAY: Promoting Men's Health at Work |
